Alemtuzumab and chronic plaque psoriasis

A. Aslam,A. Marsland,D. Rog,C. Griffiths
DOI: https://doi.org/10.1111/bjd.12226
IF: 11.113
2013-07-01
British Journal of Dermatology
Abstract:of male LS postcircumcision. Terlou et al., who performed gene-expression profiling and real-time reverse-transcription polymerase chain reaction experiments in 12 patients with VLS, recently suggested that alterations such as enhanced expression of microRNA-155 and dermal infiltrates of CD4-, CD8-, and FOXP3-positive cells indicate an autoimmune phenotype in LS. Our data give support to their results. However, an important mechanism for inducing autoimmunity is loss of immune tolerance due to the absence of the suppressive function of Tregs. Hence, the presence of increased lesional FOXP3+ cells seems to contradict the hypothesis of an LS autoimmune phenotype. Despite increased numbers of FOXP3+ cells, we observed decreased numbers of IL-10+ cells and equal counts for TGF-b1+ cells in patients with LS compared with HC. The latter finding matches the results of our previous study, indicating that TGF-b1 mRNA expression in patients with LS does not differ from HC. The mechanism of suppression by Tregs is mediated by close contact, as well as by IL-10 and TGF-b1. Hence, Tregs usually positively correlate with IL-10 and TGF-b1 expression. Terlou et al. explained their apparently conflicting results by previous observations indicating that enhanced expression of microRNA-155 results in an altered Treg phenotype, and thereby a reduced suppressive function of Tregs – despite an increase in Treg counts. Moreover, the suppressive function of Tregs can be impaired by inflammatory mediators such as tumour necrosis factor and IL-6, which have been reported to be increased in LS. The low IL-10 expression, despite the high number of FOXP3+ cells observed in patients with LS in the present study, may indicate a reduced suppressive function of these Tregs. Increased numbers of Tregs were also observed in other autoimmune conditions, such as rheumatoid arthritis, Sj€ ogren syndrome, Wegener granulomatosis and sarcoidosis. Indeed, the most common patterns found in patients with autoimmune conditions are either low number of Tregs with normal function, or normal-to-increased numbers of Tregs with reduced suppressive function. Limitations of the present study include variations in the sample size of the patient and control groups, and absence of both gene-expression analysis and functional data. Nevertheless, our preliminary data indicate that LS possibly has an autoimmune background, as characterized by a lesional increase of Tregs and a decrease of IL-10. The differences in the percentages of CD4+ and FOXP3+ lymphocytes observed in patients with VLS and PLS may also indicate different pathogenetic pathways in female and male LS. However, our preliminary results have to be substantiated in larger studies, including reasonable sample sizes and sophisticated methodology.
What problem does this paper attempt to address?